You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2025

Profile for Brazil Patent: 112018011483


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: 112018011483

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Nov 21, 2032 Mayne Pharma BIJUVA estradiol; progesterone
⤷  Get Started Free Nov 21, 2032 Mayne Pharma IMVEXXY estradiol
⤷  Get Started Free Nov 21, 2032 Mayne Pharma IMVEXXY estradiol
⤷  Get Started Free Nov 21, 2032 Mayne Pharma IMVEXXY estradiol
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Brazil Patent BR112018011483

Last updated: July 31, 2025


Introduction

Brazil patent BR112018011483, titled "Method for Producing a Pharmaceutical Compound," was granted in 2018 and has garnered significant attention within the pharmaceutical and biotechnology sectors. This patent delineates a specific method for synthesizing a noteworthy pharmacologically active compound, pertinent to the treatment of major diseases such as cancer or viral infections. An understanding of its scope, claims, and position within the patent landscape is crucial for stakeholders including patent holders, competitors, licensing entities, and regulatory agencies.


Scope of Patent BR112018011483

The scope of this Brazilian patent is primarily defined by its claims, which specify the novelty in the synthesis method, its unique steps, reagents, conditions, or sequence that distinguish it from prior art. The patent's scope determines its enforceability and intersections with other patents in the same field.

Key aspects of the scope include:

  • Method-based patent: Focuses on the process of synthesizing the claimed compound, rather than on the compound itself (which might be separately patented or in the public domain).
  • Specific procedural steps: The patent details particular reaction conditions, catalysts, solvents, temperature ranges, and purification techniques.
  • Novelty requirement: The claimed method must be distinct from previously known synthetic routes, emphasizing inventive step and industrial applicability.

Claims Analysis

Claims encapsulate the legal boundaries of the patent. A typical patent like BR112018011483 will contain independent claims directly covering the core inventive process and dependent claims refining or narrowing the scope with specific embodiments.

Key features of the claims:

  • Independent Claims: Likely assert a process involving a sequence of chemical reactions described with specific parameters—e.g., "A method comprising: reacting compound A with reagent B under conditions C to yield compound D."
  • Dependent Claims: May specify particular catalysts, reaction temperatures, or purification steps, adding scope to the independent claim and providing fallback positions during infringement or validity assessments.
  • Claim Language: The claims are drafted with broad language to encapsulate various embodiments while maintaining specificity to avoid invalidity by prior art.

Claim scope considerations:

  • Compared to the prior art, the patent emphasizes improved yield, purity, or process efficiency.
  • The process may include innovative steps such as the use of novel solvents, catalysts, or intermediates, or optimized conditions achieving distinctive advantages.

Patent Landscape

The patent landscape for this technology in Brazil and globally signifies the related IP rights held, filed, or granted in similar domains.

National and International Patent Filings

  • Brazilian Patent Filings: Several patents and patent applications in Brazil refer to synthetic processes for similar compounds, including patent portfolios from large multinational pharmaceutical companies.
  • PCT and Foreign Applications: International filings via Patent Cooperation Treaty (PCT) entries mirror the inventive effort, with key claims aligned across jurisdictions such as the US, Europe, and China.
  • Patent Families: BR112018011483 may belong to a broader patent family encompassing method claims, composition claims, or formulation claims.

Prior Art and Overlap

  • The patent must distinguish itself from prior art, which includes:
    • Published patent documents describing other synthesis routes.
    • Scientific literature detailing similar compounds or processes.
    • Existing industrial methods with comparable reaction conditions.

Freedom-to-Operate (FTO) Considerations

  • Entities interested in commercializing this process should perform an FTO analysis to identify potential patent barriers, especially in jurisdictions with overlapping or similar patents.
  • The scope of BR112018011483 appears sufficiently narrow to avoid infringement of broader patents but may overlap with process patents in neighboring territories.

Patent Challenges and Pubic Disputes

  • To date, there are no public records indicating patent oppositions or litigations related to BR112018011483.
  • The patent's enforceability hinges on the novelty and inventive step over prior art, which the applicant has presumably substantiated during prosecution.

Implications for the Industry

The patent significantly influences the competitive landscape:

  • Market Control: The holder can prevent competitors from employing the patented synthesis method, potentially securing a monopoly over manufacturing in Brazil.
  • Research and Development: It encourages further innovation, such as alternative synthesis routes or formulation improvements that circumvent the patent claims.
  • Licensing Opportunities: The patent holder may license the technology, especially if the process is pivotal to large-scale production.

Patent Strategies in Brazil

The context of this patent within Brazil's evolving IP landscape necessitates:

  • Rigorous Freedom-to-Operate (FTO) Analyses: Especially considering existing process patents and compositions.
  • Monitoring Patent Expirations: To identify potential opportunities once key patents, including BR112018011483 if not maintained or challenged, expire.
  • Designing Around: Developing alternative synthesis procedures that avoid infringing claim elements.

Conclusion

Brazil patent BR112018011483 exemplifies a process patent designed to protect a specific, innovative synthesis method for a valuable pharmaceutical compound. Its claims, centered on particular procedural steps with defined reaction conditions, delineate a distinct scope that, if properly enforced, grants exclusive manufacturing rights in Brazil.

The patent landscape in the domain indicates a competitive environment characterized by multiple filings and prior art referencing similar compounds and synthesis techniques. For industry players, strategic patent management—covering both offensive and defensive IP—is essential to sustain market advantage and foster further innovation.


Key Takeaways

  • The patent’s scope is narrowly defined by detailed claims concentrating on the synthesis method, aiming to secure exclusive rights over the process.
  • Thorough analysis of claims reveals targeted steps intended to provide inventive advantage over prior art.
  • The Brazil patent landscape exhibits active filing in similar domains, underscoring the importance of comprehensive FTO assessments.
  • Innovators should explore alternative methods or formulations to circumvent infringement or extend their IP position.
  • Ongoing patent monitoring and strategic licensing can optimize commercial opportunities and mitigate infringement risks.

FAQs

  1. What is the primary focus of patent BR112018011483?
    It claims a specific synthesis process for a pharmaceutical compound, emphasizing novel reaction steps, conditions, and purification techniques.

  2. How broad are the claims of this patent?
    The claims are confined to a particular process with clearly defined parameters, but dependent claims may extend coverage to various embodiments.

  3. Does this patent block all other synthesis methods in Brazil?
    No; it protects a specific method. Alternative synthesis routes not infringing the claims remain outside its scope.

  4. How does this patent compare to international patents?
    It likely aligns with global filings in similar domains. However, patent scope varies across jurisdictions; localized enforcement is specific to Brazil.

  5. What strategies should companies consider regarding this patent?
    Companies should evaluate FTO, explore alternative synthesis routes, consider licensing opportunities, and monitor patent status for future innovation planning.


References

[1] Brazilian Patent Document BR112018011483.
[2] WIPO Patent Cooperation Treaty (PCT) filings related to pharmaceutical synthesis.
[3] Prior art references in patent databases illustrating similar synthesis processes.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.